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Hypertension, Department of Medicine, University of Colorado Denver, Aurora, ColoradoABSTRACT Cholesterol crystals (ChCs) have been identified as a major factor of plaque vulnerability and as a potential
biomarker for atherosclerosis. Yet, due to the technical challenge of selectively detecting cholesterol in its native tissue
environment, the physiochemical role of ChCs in atherosclerotic progression remains largely unknown. In this work, we demon-
strate the utility of hyperspectral stimulated Raman scattering (SRS) microscopy combined with second-harmonic generation
(SHG) microscopy to selectively detect ChC. We show that despite the polarization sensitivity of the ChC Raman spectrum,
cholesterol monohydrate crystals can be reliably discriminated from aliphatic lipids, from structural proteins of the tissue matrix
and from other condensed structures, including cholesteryl esters. We also show that ChCs exhibit a nonvanishing SHG signal,
corroborating the noncentrosymmetry of the crystal lattice composed of chiral cholesterol molecules. However, combined
hyperspectral SRS and SHG imaging reveals that not all SHG-active structures with solidlike morphologies can be assigned
to ChCs. This study exemplifies the merit of combining SRS and SHG microscopy for an enhanced label-free chemical analysis
of crystallized structures in diseased tissue.INTRODUCTIONThe accumulation of lipids in the arterial blood vessel wall,
resulting in the formation of lipid-rich plaques, is a pro-
minent feature of atherosclerosis. Atherosclerotic plaques
can erode or rupture, which has been recognized as a
universal pathological precursor of myocardial infarction
and stroke—two major causes of death in many Western
countries (1–3). The physicochemical properties of lipids
play a prominent role in atherosclerotic disease progression.
Hence, understanding the role of lipids in plaque develop-
ment and rupture is vital for devising therapeutic strategies
for atherosclerosis.
Various studies have pointed out the correlation between
lipid content, including cholesterol and cholesteryl esters,
and the severity of the disease (4,5). It has been shown
that cholesterol crystals (ChCs) pierced the arterial intima
of patients who experienced acute coronary death. On the
other hand, patients who suffered a noncardiac-related
death did not manifest arterial perforation by ChCs, despite
having severe atherosclerosis (6–9). These observations
underline the link between presence of ChCs and acute
coronary death. More recently, the capability of ChC to
induce inflammation and its correlation with plaque area
and presence of macrophage-derived matrix metallopro-
teinase have been demonstrated (10–12), highlighting the
role of ChC in cellular processes known to exacerbate
plaque vulnerability (3,13,14). Furthermore, it has beenSubmitted January 4, 2012, and accepted for publication March 12, 2012.
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0006-3495/12/04/1988/8 $2.00suggested that solid ChC structures are also capable to phys-
ically perforate cell membranes and the plaque’s fibrous
cap, which could subsequently trigger cell apoptosis and
plaque rupture, respectively (7). Despite the importance of
ChC in atherosclerotic disease progression, the biophysical
and chemical events responsible for ChC formation and the
subsequent role of ChC in plaque aggravation remain
largely unknown. Hence, the ability to selectively detect
ChC within its native milieu in the lesion may provide
insights into the progression of ChC and atherogenesis.
Standard light microscopy has been used extensively to
examine arterial tissues. The presence of ChCs has often
been inferred from empty spaces exhibiting rodlike struc-
ture in the optical image, which are presumably the result
of dissolving ChCs with the addition of dehydrating agents
(9). In more recent studies, confocal reflection microscopy
and micro-optical coherence tomography (micro-OCT)
have been utilized to visualize ChC (11,15). Although con-
focal reflection microscopy and micro-OCT are sensitive to
the enhanced reflectivity of ChC, both techniques are not
chemically selective and thus cannot conclusively discrimi-
nate ChC from other crystallized materials in the plaque.
Similarly, lipophilic stains such as Sudan Black and Nile
Red lack accuracy and specificity (16,17). Such shortcom-
ings compromise the precise identification and quantifica-
tion of ChC, limiting the use of ChC as a biomarker for
atherosclerotic disease.
The contrast in nonlinear optical (NLO) microscopy, on
the other hand, is typically derived from optical properties
of endogenous compounds, avoiding the need for exogenousdoi: 10.1016/j.bpj.2012.03.016
Cholesterol Detection Using SRS and SHG 1989dyes and allowing three-dimensional visualization of
structures with submicron resolution (17,18). In particular,
coherent Raman techniques such as coherent anti-Stokes
Raman scattering (CARS) and stimulated Raman scattering
(SRS) provide label-free detection of lipophilic compounds
based on the intrinsic vibrational signatures of the molecules
(19,20). In recent work, we have successfully used hyper-
spectral CARS imaging, where each pixel in the image
carries information in the spectral dimension, for the identi-
fication of ChC within intact mouse aortas (20).
The spectral sensitivity of CARS enabled a clear dis-
crimination between ChC and structures with similar
morphologies. However, a detailed spectroscopic analysis
of ChCs in their native plaque environment is not straight-
forward using CARS, due to the presence of a nonresonant
electronic background (18,21). To evaluate the potential of
NLO microscopy for the study of cholesterol in atheroscle-
rosis, a more elaborate analysis of the effects of ChC orien-
tation, crystal variability, and the crystal’s immediate
surroundings on the detection sensitivity of NLO is needed.
In this work, we provide a comprehensive study of ChC
in atherosclerotic plaques with NLO microscopy. To facili-
tate the spectral analysis, we employ hyperspectral SRS
microscopy. Unlike CARS, SRS is devoid of the nonreso-
nant electronic background (18,21), which enables a direct
comparison of the ChC spectra with the Raman spectra of
in vitro standards. In addition, we examine the second-order
nonlinearity of ChCs with second-harmonic generation
(SHG) microscopy. SHG is exclusively sensitive to noncen-
trosymmetric materials such as chiral crystals, and thus can
be used to complement hyperspectral SRS in discriminating
ChCs from other amorphous lipids. We will show that the
combined SRS/SHG method is a promising approach for
identifying and interrogating cholesterol crystals and its
derivatives in atherosclerotic plaques.MATERIALS AND METHODS
SRS and SHG imaging
The Stokes and pump beams used in the SRS experiments were derived
from an optical parametric oscillator (OPO; Levante Emerald, Berlin,
Germany) pumped by a 7-ps, 76-MHz mode-locked Nd:vanadate laser
(Picotrain; High-Q, Hohenems, Austria). The Stokes beam was fixed at
1064 nm, whereas the pump beam was tuned within the 800–820-nm range.
Tuning was accomplished through computer control of the crystal temper-
ature, Lyot filter, and cavity length of the OPO. The pump and Stokes
beams were overlapped both spatially and temporally on a dichroic beam
combiner, and sent into a laser scanner (Fluoview 300; Olympus, Center
Valley, PA), illuminating the specimen with a 20, 0.75 NA objective
lens (UPlanSApo; Olympus) mounted on an inverted microscope (IX71;
Olympus).
To monitor stimulated Raman loss, the Stokes beam was modulated at
10 MHz with an acoustic optical modulator (Crystal Technology, Palo
Alto, CA). The modulated pump intensity was detected by a photodiode
(FDS1010; Thorlabs, Newton, NJ), and the signal was demodulated with
a home-built lock-in amplifier. SHG signals induced by the pump beam
were measured in both forward- and epi-direction through a bandpass filter(4005 40 nm; Thorlabs) with a photomultiplier tube (R3896; Hamamatsu,
Hamamatsu City, Japan). We note that no autofluorescence of pure choles-
terol crystals was observed within the spectral detection window. The
average combined power of Stokes and pump at the specimen was kept
under 30 mW throughout this study to ensure sample integrity.Spectral and polarization analysis
The concept of hyperspectral coherent Raman imaging based on pico-
second laser source has been discussed in several recent works (22,23),
including our own (20,24). To achieve rapid hyperspectral imaging from
2750 to 3050 cm1, with spectral resolution of ~5 cm1 (full width half-
maximum), several parameters of the OPO, including crystal temperature,
Lyot filter, and cavity length, were automatically tuned with homemade
software written in Python (http://python.org/). At each wavelength, an
SRS image was registered within a fixed field of view, whereas the output
power from the OPO was maintained at a constant level. The fastest imple-
mentation of hyperspectral SRS imaging with our setup produces data
stacks of at least 50 spectral points in 10–15 min, corresponding to an effec-
tive spectral acquisition time of 2.3–3.5 ms per pixel. Consequently, each
pixel in the image contains an SRS spectrum that can be directly compared
to Raman signatures available in the literature or obtained in vitro.
Principal component analysis (PCA) was implemented to identify
regions in the image with distinct spectral signatures. Briefly, PCA is an
unsupervised statistical method that enables multidimensional datasets
(i.e., 512  512 pixels acquired at 50 different spectral points) to be
analyzed and visualized in terms of fewer variables (i.e., most significant
variations in the dataset can be captured with 3–4 variables). A more
detailed description of PCA for spectral analysis can be found in the liter-
ature (20,25,26). SRS spectra were analyzed using ImageJ (U.S. National
Institute of Health, Bethesda, MD) andMATLAB (TheMathWorks, Natick,
MA). A commercial confocal Raman microscope with excitation wave-
length of 532 nm (InVia Confocal; Renishaw, Wotton-under-Edge, Glou-
cestershire, UK) was utilized to acquire Raman spectra of cholesterol
monohydrate.
The polarization dependence of the SRS and SHG signals was measured
by controlling the polarization orientation of the linearly and parallel polar-
ized pump and Stokes beams. An achromatic half-wave plate was utilized to
control the input polarization of both pump and Stokes beams. The signal
was collected as a function of the input polarization without the use of an
analyzer. The average pixel intensity within a region of interest (ROI) in
each image was extracted using ImageJ, and plotted using the Radar Chart
Function in Microsoft Excel (Microsoft, Redmond, WA).Specimen and sample preparation
5/6 nephrectomized ApoE-deficient mice (ApoE/; stock No. 002052)
were purchased from Jackson Laboratory (Bar Harbor, ME). At eight weeks
of age, the mice were fed a Western-style diet (0.15% cholesterol and 21%
milk fat; TD88137; Harlan Teklad, Indianapolis, IN). After 16 weeks of
Western diet, whole intact aortas were harvested, incised longitudinally,
and placed on a microscope slide with the luminal side exposed to allow
en face imaging. The specimens were fixed with 2%-paraformaldehyde,
and phosphate-buffered saline was applied before sandwiching the aorta
with glass coverslips. Animal experiments were approved by the Institu-
tional Animal Care and Research Advisory Committee of the University
of Colorado at Denver.
Cholesterol was purchased from Sigma-Aldrich (St. Louis, MO) and
used without further purification. Cholesterol monohydrate crystals were
synthesized by recrystallizing cholesterol in water. The crystals were
transferred to a glass coverslip for subsequent microspectroscopic analysis.
Raman spectra of protein and other cholesterol derivatives were obtained
from http://www.sigmaaldrich.com/, and used as a reference for spectral
analysis.Biophysical Journal 102(8) 1988–1995
1990 Suhalim et al.RESULTS
Cholesterol identification via hyperspectral SRS
imaging
To characterize the vibrational spectral signature of ChC, we
performed hyperspectral SRS in the CH stretching vibra-
tional region (2700–3100 cm1) on isolated ChCs in vitro,
obtained through recrystallization of cholesterol in water.
The Raman spectrum shows several distinct peaks, including
prominent peaks at 2855 cm1, 2869 cm1, 2907 cm1,
2945 cm1, and 2966 cm1 (Fig. 1 A). All of the spectral sig-
natures of ChC in this range are reproduced in the average
SRS spectrum.
Spectral variation was observed among the crystals
(Fig. 1 A). This variation was found to correlate strongly
with the polarization of the excitation beams. In particular,
the spectral region near the 2855 cm1 and the 2869 cm1
bands is highly polarization-dependent. In addition, the
2945 cm1 band exhibits a polarization dependence orthog-
onal to the former bands. On the other hand, the peak at
2907 cm1 is relatively insensitive to the input polarization
(Fig. 1 B). This polarization sensitivity of the CH stretching
band suggests that ChCs, which are arbitrarily oriented in
tissue, may display similar polarization-dependent spectral
variations. Thus, it is important to account for the polariza-
tion effects on the spectral signature when assigning the
crystal’s composition.
In the mouse aorta, lipid-rich structures with solidlike
morphologies were identified. In particular, various sharp
and rectangular structures were observed, including plate-0
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FIGURE 1 Vibrational signature of ChC. (A) Average spectra of isolated
ChC in vitro obtained with a Raman microscope (dashed line). Spectra were
averaged based on eight point measurements. SRS spectra at two different
laser polarizations (bottom solid lines). Average of SRS spectra at 0 and
90 (top solid line). (B) Relative intensities of selected Raman peaks
acquired at different laser polarizations.
Biophysical Journal 102(8) 1988–1995and needle-shaped structures (Fig. 2, A and D). The
extracted SRS spectra of these tissue structures are shown
in Fig. 2, C and F. The solidlike structures exhibit a spectral
profile that is virtually identical to the spectral signatures of
ChC in vitro shown in Fig. 1 A.SHG signal from cholesterol crystal
The corresponding SHG images in Fig. 2 are shown in
panels B and E. The fact that the condensed structures
with strong SRS signals also exhibit strong SHG signal indi-
cates that these structures are highly ordered on the molec-
ular level. No significant autofluorescence from structures
identified as ChC was observed within the spectral detection
window (data not shown), corroborating that bright spots in
the SHG images were indeed generated through second-
harmonic activity of the molecules.
In Fig. 3, A and B, an SRS image and SHG image of an
area rich in lipid structures are shown. Several structures
are selected and the corresponding SRS spectra are given
in Fig. 3 C. Structures that exhibited spectra with the three
distinct ChC peaks at 2869 cm1, 2907 cm1, and
2945 cm1 showed a strong SHG response. The spectra cor-
responding to the ChC rich areas with SHG activity are
given in blue. This confirms that ChC structures display a
nonvanishing SHG signature. On the other hand, the spectra
indicated with a solid black line in Fig. 3 C showed a rela-
tively strong SRS response but produced a very weak signal
in the SHG channel. It can be seen that the spectra of these
regions of interest (ROIs) are devoid of the three character-
istic ChC peaks and thus do not correspond to ChC-rich
structures. For instance, the ROI 3 shows a characteristic
amorphous aliphatic lipid spectrum, which has a strong
SRS signal but is not expected to have any SHG activity.
These observations provide strong evidence that crystallized
ChC materials in the atherosclerotic lesion are SHG-active,
whereas other amorphous lipid-rich materials are SHG-
inactive.Polarization dependence of cholesterol crystal
To further study the nature of the ChC-rich structures, the
intensity of the SRS and SHG signals was measured as
a function of laser polarization. In Fig. 4, a comparison
between the polarization dependence of the SRS and SHG
signals is shown for different ROIs. The SRS (red) and
SHG (blue) signals measured in ROI 4 and ROI 5 are polar-
ization-sensitive. It can be seen that the polarization depen-
dence of SHG signal from ROI 4 is more prominent than
ROI 5. Note that the maximum SHG intensities of ROI 4
and ROI 5 are at different polarization angles than the
maximum SRS intensities. Because SRS and SHG signals
originate from two independent processes, polarization
angles at which maximum SHG and SRS intensities occur
do not necessarily correlate. The observed polarization
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FIGURE 2 Identification of ChCs in athero-
sclerotic plaques of ApoE/ mouse. Plate- and
needle-shaped structures can be visualized in
SRS (A and D, respectively) and SHG (B and E,
respectively) channels. SRS images were acquired
at 2855 cm1. SRS spectra from highlighted re-
gions in A and D are plotted in panel C and F,
respectively (solid lines). Raman spectra from
isolated ChC are provided as a reference (dashed
lines). Scale bars: 25 mm.
Cholesterol Detection Using SRS and SHG 1991dependence nonetheless suggests that the molecules in the
ChC-rich structures are highly ordered.
The SRS signal from ROI 3 has a much weaker polariza-
tion dependence relative to ROI 4 and ROI 5. As predicted
by the SRS spectral analysis above, the amorphous aliphatic
lipids in ROI 3 exhibit virtually no SHG signal (Fig. 3 B).
These observations confirm that the lipids in ROI 3 are2800 2850 2900 2950 30000
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FIGURE 3 Spectral analysis of plaque components. Maximum projec-
tions of SRS (A) and SHG (B) images acquired at consecutive laser polar-
izations of lipid-rich area in the plaque. (C) SRS spectra extracted from
ROIs highlighted in panel A are plotted. ROIs 4–6 are SHG-active, as
evident in panel B, and exhibit spectra (solid lines) consistent with the spec-
tral signature of ChC (dashed line). In contrast, amorphous lipophilic
compounds in ROI 3 exhibit virtually no SHG signal, indicating lack of
preferential orientation. The background signal in the SHG channel can
be attributed to residual autofluorescence from the surrounding tissue
matrix. Scale bars: 10 mm.amorphous and noncrystalline in nature. The weak back-
ground signal and polarization dependence in the SHG
channel can be attributed to residual autofluorescence from
the surrounding tissue matrix.Chemical selectivity of SHG
To explore the specificity of SHG for cholesterol detection,
SRS spectra from different ROIs were analyzed. The spec-
tral analysis in Fig. 3 suggests that SHG-activity is exclusive
to ChC-rich structures. However, condensed needle-shaped
structures, which display SHG-activity but have spectra
different from the spectral signature of cholesterol monohy-
drate crystals, were also observed. An example is shown in
Fig. 5. The structure in the white ROI has a strong SRS
and SHG response. Nonetheless, peaks are observed at
2898 cm1 and 2937 cm1 that do not correspond to the
peaks of cholesterol monohydrate crystals (top dashed spec-
trum in Fig. 5 C). For comparison, the Raman spectrum of
cholesteryl oleate is also given in Fig. 5. The similarity
between the spectra from ROI and from cholesteryl oleate
suggests that the condensed structure is a cholesteryl ester
crystal rather than a cholesterol monohydrate crystal. In
addition, needles with spectral signature similar to choles-
teryl linoleate were observed (data not shown). These
observations underline that more crystalline materials found
in plaques exhibit SHG activity besides cholesterol mono-
hydrate crystals.
In addition to the SHG response of crystallized choles-
terol and cholesteryl esters, SHG signals from other tissue
components was observed. In Fig. 6, the chemical makeup
of SHG-active regions with distinct morphologies is com-
pared. A plate-shaped structure that shows strong SRS
and SHG signals is seen (Fig. 6, A and B, respectively).
The SRS spectral signature extracted from the plateBiophysical Journal 102(8) 1988–1995
A B
C
FIGURE 4 Polarization dependence of ChC. SRS microscope was tuned
to theCH2 symmetric stretch (at 2855 cm
1) to visualize lipid-richmaterials.
Polar plots of ROIs 3–5 highlighted in Fig. 3 A are shown. (Red and blue
lines) Intensities from SRS and SHG channels, respectively. Materials in
ROIs 4 and 5, which were identified as ChCs (Fig. 3 C), are SHG-active.
Additionally, both SRS and SHG signals are highly polarization-dependent,
corroborating the crystallinity of thematerials. In contrast, amorphous lipid-
rich materials in ROI 3 exhibit no SHG signal and have weak polarization
dependence, indicating lack of preferential orientation.
1992 Suhalim et al.features spectral peaks corresponding to the Raman
spectrum of ChC (Fig. 6 D; blue solid spectrum versus
black dashed spectrum, respectively). In contrast, the
SRS spectral signature extracted from the SHG-active
area below the plate-shaped structure (solid magenta spec-
trum) is consistent with the spectral signature of structural
proteins (27,28). The SHG activity in this area can be
attributed to the presence of collagen fiber (28,29). A
decomposition map based on PCAwas constructed to high-
light the distribution of pixels with ChC and protein signa-
ture (Fig. 6 C). Furthermore, needle-shaped protein-rich
structures with intense SHG-signals were observed as
well (data not shown). These observations exemplify that
the SHG signal observed in atherosclerotic plaques is not
exclusive to crystals of cholesterol monohydrate or choles-
teryl esters.Biophysical Journal 102(8) 1988–1995DISCUSSION
ChC has been gaining importance in the atherosclerosis re-
search community, with observations suggesting that these
crystals are capable of inducing inflammation—a hallmark
of atherogenesis—and physically penetrating the fibrous
cap, which consequently could increase the likelihood of
plaque rupture (7,10–12). Hence, the ability to selectively
detect ChC within intact arterial tissue is significant.
Previous optical microscopy studies have utilized either
confocal reflection microscopy or micro-OCT to identify
ChC (11,15). These two techniques are sensitive to the
enhanced reflectivity of ChC, however, both techniques
are not chemically selective, and thus cannot discriminate
ChC from other crystallized materials in the plaque.
To this end, vibrational Raman signatures of endogenous
molecules can be used to visualize and identify the chemical
makeup of various plaque components (18,30). In our recent
work, we have implemented this concept, specifically by
hyperspectral CARS imaging, and observed spectral varia-
tions among structures with similar morphologies, includ-
ing crystallized structures (20). Nonetheless, deducing the
specific composition based on CARS spectra is challenging
due to the presence of the nonresonant background, which
distorts the spectral signatures and requires advanced post-
processing to retrieve the Raman profiles (18,27,31–34).
In this study, we employed a hyperspectral imaging
scheme based on SRS, which enables a direct comparison
between Raman spectra of known lipid constituents in the
atherosclerotic plaques without spectral postprocessing.
Our study confirms that cholesterol can be reliably detected
with coherent Raman imaging techniques. The strong simi-
larity between the retrieved spectra from condensed crys-
tallike structures in the lesion and the Raman spectrum
of cholesterol monohydrate crystal in vitro indicates that
ChC in atherosclerotic plaques can be readily identified
based on its spectral signatures and solidlike morphology.
The Raman spectrum of ChC in the C-H stretching vibra-
tional range features a series of signatures that can be attrib-
uted to CH2 and CH3 stretches of cholesterol. The Raman
peak at 2855 cm1 can be confidently assigned to the sym-
metric CH2 stretching mode (35–37). The mode near
2869 cm1 has been ascribed to the symmetric CH3 stretch,
and the peak at 2966 cm1 has been attributed to theFIGURE 5 SHG is not chemically selective.
(Rectangular box) Plaque crystal, observed in
both SRS (A) and SHG (B) channels, exhibits char-
acteristic spectra (solid line in panel C) different
from spectral signature of ChC (top dashed line).
SRS image was acquired at 2855 cm1. The spec-
trum of cholesteryl-oleate is provided for com-
parison (bottom dashed line). Scale bars: 10 mm.
FIGURE 6 SHG signal is not exclusive to crystallized cholesterol. SRS
(A) and SHG (B) images of platelike structure within an atherosclerotic
plaque are shown. SRS image was acquired at 2855 cm1. Panel C is
a PCA decomposition map: pixels exhibiting spectral signature of ChC
(blue) and structural protein (magenta), respectively. SRS spectra (blue
and magenta pixels) are plotted in panel D. Not all structures with ChC
spectral signature are SHG-active, illustrating the presence of amorphous
cholesterol (circular blue structure). Other SHG-active materials (magenta
pixels) exhibit a typical structural protein spectrum, which can be attributed
to presence of collagen in the tissue. Scale bars: 30 mm.
Cholesterol Detection Using SRS and SHG 1993asymmetric CH3 stretch. The region between 2869 cm
1
and 2945 cm1 is more ambiguous due to the presence of
combination bands (35,36). Bresson et al. (36) identified
the 2907 cm1 mode as an asymmetric CH2 stretching
vibration, whereas the mode near 2945 cm1 was attributed
to a combination band. Table 1 summarizes the frequencies
and possible assignments of the C-H stretching bands of
cholesterol.
Although all ChCs in the plaque exhibited the distinct
vibrational signatures listed in Table 1, the relative intensi-
ties of the bands changed from crystal to crystal. Our polar-
ization studies on ChCs in the plaque and ChCs grown
in vitro confirm that these spectral intensity changes are
due to the orientation of the modes relative to the polariza-
tion orientation of the excitation light. Among the modes
identified, the region near the symmetric CH2 mode vibra-
tion (~2855 cm1) and the 2945 cm1 mode show a strong
polarization dependence, whereas the other modes are rela-
tively insensitive to the polarization orientation of the exci-TABLE 1 Raman bands assignment of ChC
Peak position CH stretching modes
2855 cm1 CH2 symmetric
2869 cm1 CH3 symmetric
2907 cm1 CH2 asymmetric
2945 cm1 CH3 symmetric or CH2 asymmetric
2966 cm1 CH3 asymmetric
Values from Faiman (35) and Bresson et al. (36).tation beams. The crystal structure of the cholesterol
molecule shows a relatively planar configuration, in which
the polarizability axis of the symmetric CH2 stretching
mode is predominantly aligned in the plane of the molecule
(38,39). The consistent orientation of the symmetric CH2
mode in the cholesterol molecule complies with the
strong polarization dependence observed. The polarization
dependence of the 2945 cm1 mode is orthogonal to the
polarization dependence of the symmetric CH2 stretch, indi-
cating that polarizability direction of this mode is orthog-
onal to the symmetric CH2 mode. Despite the spectral
changes due to the orientation of the cholesterol crystals,
the Raman spectral markers occur at fixed frequencies,
thus enabling a confident detection of randomly oriented
ChCs in atherosclerotic plaques with hyperspectral SRS
microscopy.
In addition to their strong SRS signal, ChC can also be
visualized based on its nonvanishing second-order nonline-
arity with SHGmicroscopy (Figs. 2, 3, and 6). Whereas SRS
detects ChC based on the C-H vibrational contrast, the
SHG signal from ChC arises from the noncentrosymmetry
of the chiral cholesterol molecules in the crystal lattice,
giving rise to a finite second-order susceptibility (40).
Accordingly, the SHG signal can be used to assess the crys-
tallinity of condensed ChC structures in the aorta. Our
studies confirm the SHG-activity of crystallized cholesterol.
Additionally, the SHG signal from these crystals was found
to be polarization-sensitive, further corroborating the
ordered crystalline structure of the materials identified as
ChC (Fig. 3). We found that other ordered structures in
the plaque, including needles of cholesteryl esters, also
produced nonvanishing SHG signals. Similarly, protein
crystals and ordered structural proteins such as fibrous
collagen exhibit significant SHG signals, as shown in
numerous studies (29,40–42). Therefore, although SHG
imaging provides useful information about the crystallinity
of the structures found in atherosclerotic lesions, this
modality alone is insufficient to exclusively identify ChC.
The use of hyperspectral coherent Raman microscopy
proved essential for the reliable detection of ChC.
Most of the crystallized structures shown in this study
were located near the ascending and aortic arch regions of
the ApoE-deficient mouse aorta, consistent with previous
findings (11,19,20). The length of these crystals ranges
from 4 mm for a single needle up to 50 mm for an agglom-
eration of plates. Among these crystals, we identified
different classes of cholesterol, including cholesterol mono-
hydrate, cholesteryl oleate, and cholesteryl linoleate—
known as key lipids in atherogenesis (43,44). The structures
identified as ChC, as expected, exhibit strong SHG activity.
In contrast, structures with amorphous morphologies and
spectral signatures other than ChC, did not exhibit a strong
SHG signal or polarization dependence. Structures with the
latter properties can be ruled out as being ChC. For example,
the amorphous circular structure adjacent to the plate inBiophysical Journal 102(8) 1988–1995
1994 Suhalim et al.Fig. 5, exhibits cholesterol spectral signatures but virtually
no SHG activity; we attribute these structures to liquid,
noncrystalline, cholesterol. Given the fast imaging speed
and compatibility of SHG with the coherent Raman plat-
form, SHG stands out as a suitable NLO partner for SRS
to discriminate crystalline structures such as ChC from
amorphous components in the plaque, obviating additional
morphological assessment that can be subjective at times.
The fast imaging speed of SHG is also useful for sample
browsing of large tissue area and can help guide the micros-
copist to locate the presence of crystallized materials and
collagen in the lesion. Subsequently, hyperspectral SRS
can be utilized to study the specific composition of the crys-
tallized materials.
Combined SRS and SHG imaging enables a clear separa-
tion between lipophilic compounds and other tissue mate-
rials. For instance, collagen is ubiquitous in aortic tissue
and produces strong signals in both the SRS and SHG chan-
nels (29,41), but can be accurately discriminated from lipid-
type structures. Additionally, micrometer needle-shaped
structures with spectra characteristic of structural protein
was found in the aorta as well (28). Interestingly, these
protein-needles also exhibit a strong SHG signal and polar-
ization dependence (data not shown), which can be attrib-
uted to highly condensed structural proteins or protein
crystals (40). Further study is required to determine the
origin and role of these protein needles in the plaque.
Out of the three types of ChC observed in this study,
cholesterol monohydrate crystals comprise the majority of
ChC in the aorta. Moreover, all the plate-shaped crystals
are composed of cholesterol monohydrate, whereas the
composition of the needle-shaped crystals varies, in agree-
ment with several in vitro studies (45–47). The prevalence
of cholesterol monohydrate crystals is also consistent with
previous observations in atherosclerotic lesions and other
pathologies such as lithogenic bile (46,48). In this regard,
several studies have suggested the contribution of choles-
terol-rich erythrocyte membrane to the accumulation of
free-cholesterol and subsequent crystallization in the plaque
(7,49). Solomonov et al. (50) have shown the importance
of sterol-water interface in ChC formation within cell
membranes, supporting the hypothesis of cholesterol mono-
hydrate crystallization within the erythrocyte membrane. A
recent study by Rajama¨ki et al. (10) has shown that macro-
phages, which ingest ChC, are also capable of storing the
partially digested ChC monohydrates as cholesteryl-esters.
Such occurrence may be responsible for the crystallization
of cholesteryl-esters and may potentially explain the lower
abundance of cholesteryl-ester crystals in this study. A
more comprehensive investigation, involving a time-series
characterization of ChC in mice in different diet regimes,
is required to further our understanding of the origin and
role of various ChC materials in atherosclerosis. The precise
identification and quantification of ChC with NLO tech-
niques may prove indispensable for such investigations.Biophysical Journal 102(8) 1988–1995CONCLUSION
Previous studies have inferred the presence of ChC in tissue
based on its solidlike morphology. To better understand the
physiochemical origin of ChC, its specific role in plaque
vulnerability and potential use as a biomarker for atheropro-
gression, a chemically selective tool that can probe ChC
within its native cellular milieu is a prerequisite. In this
study, we utilized two NLO imaging modalities, SHG and
hyperspectral SRS microscopy, to interrogate the composi-
tion of solidlike structures in aortas of diseased mice. We
found that despite the polarization dependence of the ChC
Raman spectrum, the distinct spectral signatures permit
a reliable identification of cholesterol monohydrate crystals.
Moreover, the spectral analysis enabled by hyperspectral
SRS imaging allows discrimination of cholesterol mono-
hydrate crystals from other condensed structures in the
tissue, including condensed cholesteryl esters. In addition,
we observed SHG activity from plate- and needle-shaped
solids within intact plaques, corroborating the crystallinity
of the ChC structures. However, the nonvanishing SHG-
activity of other structures in the tissue indicates that SHG
microscopy alone is insufficient for identifying ChC mate-
rials in atherosclerotic plaques, underlining the merits of
a combined hyperspectral SRS and SHG approach.
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